|
GALT Galectin Therapeutics Inc. Common Stock 1133416 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-9,113,000.00 |
| Balance Sheet |
|
Current Assets
|
$14,659,000.00 |
|
Assets
|
$14,826,000.00 |
|
Current Liabilities
|
$151,619,000.00 |
|
Liabilities
|
$151,678,000.00 |
|
Equity
|
$-138,575,000.00 |
|
Shares Out
|
66311910.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-6,305,000.00 |
| Market Analysis |
Market Cap
|
$236,733,518.70 |
|
Price
|
$3.57 |
|
PB
|
3.86 |
|
EPS
|
-0.14 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:47 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:38 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GALT documents filed with the SEC.
GALT Filings
Clear
